Study identity card

INVENT

United Kingdom United States
Share
  • Study type: Randomised Clinical Trial, Treatment
  • Study type descriptors: Randomised controlled trial, Multicentre
  • Objective: To investigate the potential of SNG001 to improve outcomes in mechanically ventilated patients with respiratory viral infections
  • Number of participants enrolled: 11
  • Study enrolling from to
  • Study includes follow-up for 28 days

Study Data

  • Adults (18-64 years)
  • Elderly (≥65 years)
  • Immunocompromised patients
  • Hospital
  • SARS-CoV-2
  • Respiratory syncytial virus
  • Influenza virus
  • Adenovirus
  • Rhinovirus
  • Human metapneumovirus
  • Parainfluenza Virus
  • Pharmacological intervention
  • Antivirals
  • SNG001

Other information

If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it

The data is updated up to